Article
The H6D variant of NAG-1/GDF15 inhibits prostate xenograft growth in vivo.
The Prostate - 1 May 2012
Wang Xingya, Chrysovergis Kali, Bienstock Rachelle J, Shim Minsub, Eling Thomas E
Abstract excerpt
BACKGROUND: Non-steroidal anti-inflammatory drug-activated gene (NAG-1), a divergent member of the transforming growth factor-beta superfamily, has been implicated in many cellular processes, including inflammation, early bone formation, apoptosis, and tumorigenesis. Recent clinical studies suggests that a C to G single nucleotide polymorphism at position 6 (histidine to aspartic acid substitution, or H6D) of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
